Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is 2.946.308,77 ₫, with a 24-hour trading volume of 15,1T ₫. The asset's market cap is 7,27P ₫, after moving -2.37% in the last day.
Tokenized Merck & Co Inc is trading at 2.966.798,94 ₫, with a tokenized market cap of 22,2B ₫ and a 24-hour trading volume of 23,56B ₫. The tokenized asset has moved -1.01% in the past 24 hours.